Very early effect of DMBA and MNU on microRNA expression

In Vivo. 2013 Jan-Feb;27(1):113-7.

Abstract

Background: microRNA expression profile analysis provides evaluation of the early stages of carcinogenesis. This study focuses on early alteration of miRNA expression after treatment with different carcinogens.

Materials and methods: Mice were intraperitoneally injected with one dose of 7,12-dimethylbenz(α)anthracene (DMBA) and N-methyl-N-nitrosourea (MNU). The expression of miRNAs were analyzed 3 and 6 hours after the treatment, using quantitative real-time-polymerase chain reaction.

Results: Underexpression of miR-34a and miR-155 were detected in the liver, spleen and kidneys at 3 and 6 hours after MNU treatment. In the lungs and kidneys, the expression of miR-21 was significantly elevated 6 hours after DMBA treatment, while in the liver, MNU induced higher expression levels of miR-21 at 3 and 6 hours compared to treatment with DMBA.

Conclusion: The different response of miRNAs to carcinogens emphasizes their possible role as potential epidemiological biomarkers in early phases of environmental tumorigenesis.

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene / toxicity*
  • Alkylating Agents / toxicity
  • Animals
  • Carcinogens / toxicity
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects*
  • Kidney / drug effects
  • Kidney / metabolism
  • Liver / drug effects
  • Liver / metabolism
  • Lung / drug effects
  • Lung / metabolism
  • Methylnitrosourea / toxicity*
  • Mice
  • Mice, Inbred CBA
  • MicroRNAs / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Spleen / drug effects
  • Spleen / metabolism
  • Time Factors

Substances

  • Alkylating Agents
  • Carcinogens
  • MIRN21 microRNA, mouse
  • MIRN34a microRNA, mouse
  • MicroRNAs
  • Mirn155 microRNA, mouse
  • 9,10-Dimethyl-1,2-benzanthracene
  • Methylnitrosourea